Inogen, Inc. Announces Resignation of Jason Somer as Executive Vice President, General Counsel and Secretary, Effective July 19, 2024
July 04, 2024 at 01:45 am IST
Share
On July 2, 2024, Inogen, Inc. and Jason Somer, Executive Vice President, General Counsel and Secretary of the Company, mutually determined that Mr. Somer would separate from the Company on July 19, 2024. In connection with the separation of Mr. Somer?s employment with the Company, the Company expects to enter into a Separation Agreement with Mr. Somer that will provide Mr. Somer with benefits consistent with the terms of Mr. Somer?s Employment and Severance Agreement with the Company, dated July 12, 2021. The material terms of any such Separation Agreement entered into between the Company and Mr. Somer will be disclosed in an applicable subsequent public filing with the Securities and Exchange Commission.
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.
INOGEN, INC. 
